{"count": 23, "results": [{"_id": "35495972", "pmid": 35495972, "pmcid": "PMC9052063", "title": "Delayed inflammatory reaction to hyaluronic acid filler following Shingrix and Fluzone vaccines treated with lisinopril", "journal": "JAAD Case Rep", "authors": ["Witt J", "Hooper D", "Munavalli GG"], "date": "2022-04-01T00:00:00Z", "doi": "10.1016/j.jdcr.2022.03.018", "meta_date_publication": "2022 May", "meta_volume": "23", "meta_issue": "", "meta_pages": "133-135", "score": 50260.7, "text_hl": "Delayed @<m>DISEASE_Inflammation</m> @DISEASE_MESH:D007249 @@@inflammatory@@@ reaction to @CHEMICAL_Hyaluronic_Acid @CHEMICAL_MESH:D006820 @@@hyaluronic acid@@@ filler following Shingrix and Fluzone vaccines treated with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@", "citations": {"NLM": "Witt J, Hooper D, Munavalli GG. Delayed inflammatory reaction to hyaluronic acid filler following Shingrix and Fluzone vaccines treated with lisinopril JAAD Case Rep. 2022 May;23():133-135. PMID: 35495972", "BibTeX": "@article{35495972, title={Delayed inflammatory reaction to hyaluronic acid filler following Shingrix and Fluzone vaccines treated with lisinopril}, author={Witt J and Hooper D and Munavalli GG}, journal={JAAD Case Rep}, volume={23}, pages={133-135}}"}}, {"_id": "40009171", "pmid": 40009171, "title": "Impact of lisinopril on cisplatin-induced inflammation, oxidative stress, apoptosis, and impaired steroidogenesis in rat testis: involvement of Nrf2/Keap1/HO-1 and PPARgamma signaling.", "journal": "Naunyn Schmiedebergs Arch Pharmacol", "authors": ["Arafa EA", "Hassanein EHM", "Hussein RM", "Mohamed WR"], "date": "2025-02-26T00:00:00Z", "doi": "10.1007/s00210-025-03924-3", "meta_date_publication": "2025 Feb 26", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50254.902, "text_hl": "This study investigates, for the first time, the ability of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@LSP@@@ to counteract @CHEMICAL_Cisplatin @CHEMICAL_MESH:D002945 @@@CDDP@@@-induced @<m>DISEASE_Inflammation</m> @DISEASE_MESH:D007249 @@@inflammation@@@, oxidative stress, apoptosis, and steroidogenic disturbances in @SPECIES_10116 @@@rat@@@ testis. ", "citations": {"NLM": "Arafa EA, Hassanein EHM, Hussein RM, Mohamed WR. Impact of lisinopril on cisplatin-induced inflammation, oxidative stress, apoptosis, and impaired steroidogenesis in rat testis: involvement of Nrf2/Keap1/HO-1 and PPARgamma signaling. Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 26;():. PMID: 40009171", "BibTeX": "@article{40009171, title={Impact of lisinopril on cisplatin-induced inflammation, oxidative stress, apoptosis, and impaired steroidogenesis in rat testis: involvement of Nrf2/Keap1/HO-1 and PPARgamma signaling.}, author={Arafa EA and Hassanein EHM and Hussein RM and Mohamed WR}, journal={Naunyn Schmiedebergs Arch Pharmacol}}"}}, {"_id": "35764864", "pmid": 35764864, "title": "Targeting inflammation and redox perturbations by lisinopril mitigates Freund's adjuvant-induced arthritis in rats: role of JAK-2/STAT-3/RANKL axis, MMPs, and VEGF.", "journal": "Inflammopharmacology", "authors": ["Arab HH", "Abd El-Aal SA", "Ashour AM", "El-Sheikh AAK", "Al Khabbaz HJ", "Arafa EA", "Mahmoud AM", "Kabel AM"], "date": "2022-10-01T00:00:00Z", "doi": "10.1007/s10787-022-00998-w", "meta_date_publication": "2022 Oct", "meta_volume": "30", "meta_issue": "5", "meta_pages": "1909-1926", "score": 50250.71, "text_hl": "CONCLUSION: @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ attenuated adjuvant-induced @DISEASE_Arthritis @DISEASE_MESH:D001168 @@@arthritis@@@ via inhibition of @<m>DISEASE_Inflammation</m> @DISEASE_MESH:D007249 @@@inflammation@@@, articular degradation cues, and angiogenesis.", "citations": {"NLM": "Arab HH, Abd El-Aal SA, Ashour AM, El-Sheikh AAK, Al Khabbaz HJ, Arafa EA, Mahmoud AM, Kabel AM. Targeting inflammation and redox perturbations by lisinopril mitigates Freund's adjuvant-induced arthritis in rats: role of JAK-2/STAT-3/RANKL axis, MMPs, and VEGF. Inflammopharmacology. 2022 Oct;30(5):1909-1926. PMID: 35764864", "BibTeX": "@article{35764864, title={Targeting inflammation and redox perturbations by lisinopril mitigates Freund's adjuvant-induced arthritis in rats: role of JAK-2/STAT-3/RANKL axis, MMPs, and VEGF.}, author={Arab HH and Abd El-Aal SA and Ashour AM and El-Sheikh AAK and Al Khabbaz HJ and Arafa EA and Mahmoud AM and Kabel AM}, journal={Inflammopharmacology}, volume={30}, number={5}, pages={1909-1926}}"}}, {"_id": "34975523", "pmid": 34975523, "pmcid": "PMC8719629", "title": "Treatment With Lisinopril Prevents the Early Progression of Glomerular Injury in Obese Dahl Salt-Sensitive Rats Independent of Lowering Arterial Pressure", "journal": "Front Physiol", "authors": ["Brown AK", "Nichols A", "Coley CA", "Ekperikpe US", "McPherson KC", "Shields CA", "Poudel B", "Cornelius DC", "Williams JM"], "date": "2021-12-17T00:00:00Z", "doi": "10.3389/fphys.2021.765305", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "765305", "score": 50248.613, "text_hl": "Chronic treatment with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ significantly decreased @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@glomerular injury@@@ and @<m>DISEASE_Inflammation</m> @DISEASE_MESH:D007249 @@@renal inflammation@@@ in the SSLepRmutant @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Brown AK, Nichols A, Coley CA, Ekperikpe US, McPherson KC, Shields CA, Poudel B, Cornelius DC, Williams JM. Treatment With Lisinopril Prevents the Early Progression of Glomerular Injury in Obese Dahl Salt-Sensitive Rats Independent of Lowering Arterial Pressure Front Physiol. 2021;12():765305. PMID: 34975523", "BibTeX": "@article{34975523, title={Treatment With Lisinopril Prevents the Early Progression of Glomerular Injury in Obese Dahl Salt-Sensitive Rats Independent of Lowering Arterial Pressure}, author={Brown AK and Nichols A and Coley CA and Ekperikpe US and McPherson KC and Shields CA and Poudel B and Cornelius DC and Williams JM}, journal={Front Physiol}, volume={12}, pages={765305}}"}}, {"_id": "34180715", "pmid": 34180715, "title": "Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease.", "journal": "Am J Physiol Renal Physiol", "authors": ["Østergaard MV", "Secher T", "Christensen M", "Salinas CG", "Roostalu U", "Skytte JL", "Rune I", "Hansen HH", "Jelsing J", "Vrang N", "Fink LN"], "date": "2021-08-01T00:00:00Z", "doi": "10.1152/ajprenal.00154.2021", "meta_date_publication": "2021 Aug 1", "meta_volume": "321", "meta_issue": "2", "meta_pages": "F149-F161", "score": 50244.723, "text_hl": "Total glomerular numbers and individual glomerular volume were evaluated by whole kidney three-dimensional imaging analysis. db/db UNx-ReninAAV @SPECIES_10090 @@@mice@@@ developed hallmarks of progressive @DISEASE_Diabetic_Nephropathies @DISEASE_MESH:D003928 @@@DKD@@@ characterized by severe @DISEASE_Albuminuria @DISEASE_MESH:D000419 @@@albuminuria@@@, advanced @DISEASE_Glomerulonephritis @DISEASE_MESH:D005921 @@@glomerulosclerosis@@@, and @DISEASE_Hypertrophy @DISEASE_MESH:D006984 @@@glomerular hypertrophy@@@. @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ significantly improved @DISEASE_Albuminuria @DISEASE_MESH:D000419 @@@albuminuria@@@, @DISEASE_Glomerulonephritis @DISEASE_MESH:D005921 @@@glomerulosclerosis@@@, @DISEASE_Nephritis_Interstitial @DISEASE_MESH:D009395 @@@tubulointerstitial injury@@@, and @<m>DISEASE_Inflammation</m> @DISEASE_MESH:D007249 @@@inflammation@@@. ", "citations": {"NLM": "Østergaard MV, Secher T, Christensen M, Salinas CG, Roostalu U, Skytte JL, Rune I, Hansen HH, Jelsing J, Vrang N, Fink LN. Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease. Am J Physiol Renal Physiol. 2021 Aug 1;321(2):F149-F161. PMID: 34180715", "BibTeX": "@article{34180715, title={Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease.}, author={Østergaard MV and Secher T and Christensen M and Salinas CG and Roostalu U and Skytte JL and Rune I and Hansen HH and Jelsing J and Vrang N and Fink LN}, journal={Am J Physiol Renal Physiol}, volume={321}, number={2}, pages={F149-F161}}"}}, {"_id": "36300543", "pmid": 36300543, "title": "The effect of diminazene, an angiotensin-converting enzyme 2 activator, on adenine-induced chronic kidney disease in rats.", "journal": "Fundam Clin Pharmacol", "authors": ["Abdelrahman AM", "Ali BH", "Ali H", "Manoj P", "Al-Suleimani Y"], "date": "2022-10-27T00:00:00Z", "doi": "10.1111/fcp.12845", "meta_date_publication": "2022 Oct 27", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50240.203, "text_hl": "The protective effect of the three drugs used is, at least partially, due to their anti-@<m>DISEASE_Inflammation</m> @DISEASE_MESH:D007249 @@@inflammatory@@@ and antioxidant effects. ", "citations": {"NLM": "Abdelrahman AM, Ali BH, Ali H, Manoj P, Al-Suleimani Y. The effect of diminazene, an angiotensin-converting enzyme 2 activator, on adenine-induced chronic kidney disease in rats. Fundam Clin Pharmacol. 2022 Oct 27;():. PMID: 36300543", "BibTeX": "@article{36300543, title={The effect of diminazene, an angiotensin-converting enzyme 2 activator, on adenine-induced chronic kidney disease in rats.}, author={Abdelrahman AM and Ali BH and Ali H and Manoj P and Al-Suleimani Y}, journal={Fundam Clin Pharmacol}}"}}, {"_id": "31710167", "pmid": 31710167, "title": "Clofibrate, a PPAR-alpha agonist, abrogates sodium fluoride-induced neuroinflammation, oxidative stress, and motor incoordination via modulation of GFAP/Iba-1/anti-calbindin signaling pathways.", "journal": "Environ Toxicol", "authors": ["Oyagbemi AA", "Adebiyi OE", "Adigun KO", "Ogunpolu BS", "Falayi OO", "Hassan FO", "Folarin OR", "Adebayo AK", "Adejumobi OA", "Asenuga ER", "Ola-Davies OE", "Omobowale TO", "Olopade JO", "Saba AB", "Adedapo AA", "Nkadimeng SM", "McGaw LJ", "Oguntibeju OO", "Yakubu MA"], "date": "2020-02-01T00:00:00Z", "doi": "10.1002/tox.22861", "meta_date_publication": "2020 Feb", "meta_volume": "35", "meta_issue": "2", "meta_pages": "242-253", "score": 50239.824, "text_hl": "Overall, cotreatment of @CHEMICAL_Sodium_Fluoride @CHEMICAL_MESH:D012969 @@@NaF@@@ with either @CHEMICAL_Clofibrate @CHEMICAL_MESH:D002994 @@@clofibrate@@@ or @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ showed neuroprotective effects by mitigating @<m>DISEASE_Inflammation</m> @DISEASE_MESH:D007249 @@@neuronal inflammation@@@ and oxidative and @DISEASE_Motor_Disorders @DISEASE_MESH:D000068079 @@@motor@@@ @DISEASE_Ataxia @DISEASE_MESH:D001259 @@@incoordination@@@. ", "citations": {"NLM": "Oyagbemi AA, Adebiyi OE, Adigun KO, Ogunpolu BS, Falayi OO, Hassan FO, Folarin OR, Adebayo AK, Adejumobi OA, Asenuga ER, Ola-Davies OE, Omobowale TO, Olopade JO, Saba AB, Adedapo AA, Nkadimeng SM, McGaw LJ, Oguntibeju OO, Yakubu MA. Clofibrate, a PPAR-alpha agonist, abrogates sodium fluoride-induced neuroinflammation, oxidative stress, and motor incoordination via modulation of GFAP/Iba-1/anti-calbindin signaling pathways. Environ Toxicol. 2020 Feb;35(2):242-253. PMID: 31710167", "BibTeX": "@article{31710167, title={Clofibrate, a PPAR-alpha agonist, abrogates sodium fluoride-induced neuroinflammation, oxidative stress, and motor incoordination via modulation of GFAP/Iba-1/anti-calbindin signaling pathways.}, author={Oyagbemi AA and Adebiyi OE and Adigun KO and Ogunpolu BS and Falayi OO and Hassan FO and Folarin OR and Adebayo AK and Adejumobi OA and Asenuga ER and Ola-Davies OE and Omobowale TO and Olopade JO and Saba AB and Adedapo AA and Nkadimeng SM and McGaw LJ and Oguntibeju OO and Yakubu MA}, journal={Environ Toxicol}, volume={35}, number={2}, pages={242-253}}"}}, {"_id": "31794021", "pmid": 31794021, "title": "Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.", "journal": "Brain", "authors": ["Koronyo-Hamaoui M", "Sheyn J", "Hayden EY", "Li S", "Fuchs DT", "Regis GC", "Lopes DHJ", "Black KL", "Bernstein KE", "Teplow DB", "Fuchs S", "Koronyo Y", "Rentsendorj A"], "date": "2020-01-01T00:00:00Z", "doi": "10.1093/brain/awz364", "meta_date_publication": "2020 Jan 1", "meta_volume": "143", "meta_issue": "1", "meta_pages": "336-358", "score": 50220.15, "text_hl": "Beneficial ACE10 phenotype was reversed by the @GENE_ACE @GENE_11421 @@@angiotensin-converting enzyme@@@ inhibitor (@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@) and thus was dependent on @GENE_ACE @GENE_11421 @@@angiotensin-converting enzyme@@@ catalytic activity. ", "citations": {"NLM": "Koronyo-Hamaoui M, Sheyn J, Hayden EY, Li S, Fuchs DT, Regis GC, Lopes DHJ, Black KL, Bernstein KE, Teplow DB, Fuchs S, Koronyo Y, Rentsendorj A. Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease. Brain. 2020 Jan 1;143(1):336-358. PMID: 31794021", "BibTeX": "@article{31794021, title={Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.}, author={Koronyo-Hamaoui M and Sheyn J and Hayden EY and Li S and Fuchs DT and Regis GC and Lopes DHJ and Black KL and Bernstein KE and Teplow DB and Fuchs S and Koronyo Y and Rentsendorj A}, journal={Brain}, volume={143}, number={1}, pages={336-358}}"}}, {"_id": "22937315", "pmid": 22937315, "pmcid": "PMC3420419", "title": "An Unusual Cause of Anaemia of Chronic Disease: Lisinopril-Induced Chronic Inflammatory State", "journal": "Case Rep Hematol", "authors": ["Eyre T", "Van-Hamel-Parsons V", "Wang LM", "Hughes KA", "Littlewood TJ"], "date": "2011-01-01T00:00:00Z", "doi": "10.1155/2011/939080", "meta_date_publication": "2011", "meta_volume": "2011", "meta_issue": "", "meta_pages": "939080", "score": 50068.547, "text_hl": "Evidence that the cause of her symptoms was a systemic @<m>DISEASE_Inflammation</m> @DISEASE_MESH:D007249 @@@inflammatory@@@ reaction to @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ is circumstantial but strongly supported by the onset and subsequent decline of local @DISEASE_Signs_and_Symptoms_Digestive @DISEASE_MESH:D012817 @@@(upper gastrointestinal) symptoms@@@, systemic symptoms (malaise, @DISEASE_Anorexia @DISEASE_MESH:D000855 @@@anorexia@@@, @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight loss@@@), and the systemic @<m>DISEASE_Inflammation</m> @DISEASE_MESH:D007249 @@@inflammatory@@@ response. ", "citations": {"NLM": "Eyre T, Van-Hamel-Parsons V, Wang LM, Hughes KA, Littlewood TJ. An Unusual Cause of Anaemia of Chronic Disease: Lisinopril-Induced Chronic Inflammatory State Case Rep Hematol. 2011;2011():939080. PMID: 22937315", "BibTeX": "@article{22937315, title={An Unusual Cause of Anaemia of Chronic Disease: Lisinopril-Induced Chronic Inflammatory State}, author={Eyre T and Van-Hamel-Parsons V and Wang LM and Hughes KA and Littlewood TJ}, journal={Case Rep Hematol}, volume={2011}, pages={939080}}"}}, {"_id": "7674133", "pmid": 7674133, "title": "Toxicodynamic analysis of inflammatory reactions by an angiotensin converting enzyme inhibitor (lisinopril) in guinea-pig skin.", "journal": "J Pharm Pharmacol", "authors": ["Ito K", "Ito K", "Sawada Y", "Iga T"], "date": "1995-06-01T00:00:00Z", "doi": "10.1111/j.2042-7158.1995.tb05838.x", "meta_date_publication": "1995 Jun", "meta_volume": "47", "meta_issue": "6", "meta_pages": "499-502", "score": 50063.117, "text_hl": "@<m>DISEASE_Inflammation</m> @DISEASE_MESH:D007249 @@@Inflammatory@@@ responses were dose-dependently enhanced by treatment with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@. ", "citations": {"NLM": "Ito K, Ito K, Sawada Y, Iga T. Toxicodynamic analysis of inflammatory reactions by an angiotensin converting enzyme inhibitor (lisinopril) in guinea-pig skin. J Pharm Pharmacol. 1995 Jun;47(6):499-502. PMID: 7674133", "BibTeX": "@article{7674133, title={Toxicodynamic analysis of inflammatory reactions by an angiotensin converting enzyme inhibitor (lisinopril) in guinea-pig skin.}, author={Ito K and Ito K and Sawada Y and Iga T}, journal={J Pharm Pharmacol}, volume={47}, number={6}, pages={499-502}}"}}]}